Cargando…

Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM)

BACKGROUND: The trapping mechanisms of the PET hypoxia imaging agent copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) ((64)Cu(ATSM)) remain unresolved, although its reduction prior to dissociation may be mediated by intracellular thiols. Glutathione (GSH) is the most abundant intracellular thio...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaughnessy, Fiona, Mariotti, Erika, Shaw, Karen P, Eykyn, Thomas R, Blower, Philip J, Siow, Richard, Southworth, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883992/
https://www.ncbi.nlm.nih.gov/pubmed/26055939
http://dx.doi.org/10.1186/s13550-014-0040-8
_version_ 1782434318244642816
author Shaughnessy, Fiona
Mariotti, Erika
Shaw, Karen P
Eykyn, Thomas R
Blower, Philip J
Siow, Richard
Southworth, Richard
author_facet Shaughnessy, Fiona
Mariotti, Erika
Shaw, Karen P
Eykyn, Thomas R
Blower, Philip J
Siow, Richard
Southworth, Richard
author_sort Shaughnessy, Fiona
collection PubMed
description BACKGROUND: The trapping mechanisms of the PET hypoxia imaging agent copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) ((64)Cu(ATSM)) remain unresolved, although its reduction prior to dissociation may be mediated by intracellular thiols. Glutathione (GSH) is the most abundant intracellular thiol, and its redox status changes in cancer cells and ischaemic myocardium (two prime applications for (64)Cu(ATSM) PET). We therefore investigated whether modification of intracellular GSH content affects the hypoxia selectivity of (64)Cu(ATSM). METHODS: Isolated rat hearts (n = five per group) were perfused with aerobic buffer (equilibrated with 95%O(2)/5%CO(2)) for 15 min, then hypoxic buffer (95%N(2)/5%CO(2)) for 20 min. Cardiac glutathione was depleted by buthionine sulphoximine (BSO, 4 mmol/kg/ 48 h intraperitoneal), or augmented by N-acetyl cysteine (NAC, 4 mmol/L) in the perfusion buffer. Cardiac (64)Cu retention from three 2-MBq bolus injections of (64)Cu(ATSM) before and during hypoxia was then monitored by NaI detectors. RESULTS: Cardiac GSH content was elevated by NAC and depleted by BSO (from 7.9 ± 2.0 to 59.3 ± 8.3 nmol/mg and 3.7 ± 1.0 nmol/mg protein, respectively; p < 0.05). Hypoxia did not affect cardiac GSH content in any group. During normoxia, tracer washed out bi-exponentially, with 13.1% ± 1.7% injected dose being retained; this was not affected by GSH augmentation or depletion. Hypoxia significantly increased tracer retention (to 59.1% ± 6.3%, p < 0.05); this effect was not modified by GSH augmentation or depletion. CONCLUSION: Modification of GSH levels had no impact upon the pharmacokinetics or hypoxia selectivity of (64)Cu(ATSM). While thiols may yet prove essential for the intracellular trapping of (64)Cu(ATSM), they are not the determinants of its hypoxia selectivity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13550-014-0040-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4883992
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-48839922016-06-21 Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM) Shaughnessy, Fiona Mariotti, Erika Shaw, Karen P Eykyn, Thomas R Blower, Philip J Siow, Richard Southworth, Richard EJNMMI Res Original Research BACKGROUND: The trapping mechanisms of the PET hypoxia imaging agent copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) ((64)Cu(ATSM)) remain unresolved, although its reduction prior to dissociation may be mediated by intracellular thiols. Glutathione (GSH) is the most abundant intracellular thiol, and its redox status changes in cancer cells and ischaemic myocardium (two prime applications for (64)Cu(ATSM) PET). We therefore investigated whether modification of intracellular GSH content affects the hypoxia selectivity of (64)Cu(ATSM). METHODS: Isolated rat hearts (n = five per group) were perfused with aerobic buffer (equilibrated with 95%O(2)/5%CO(2)) for 15 min, then hypoxic buffer (95%N(2)/5%CO(2)) for 20 min. Cardiac glutathione was depleted by buthionine sulphoximine (BSO, 4 mmol/kg/ 48 h intraperitoneal), or augmented by N-acetyl cysteine (NAC, 4 mmol/L) in the perfusion buffer. Cardiac (64)Cu retention from three 2-MBq bolus injections of (64)Cu(ATSM) before and during hypoxia was then monitored by NaI detectors. RESULTS: Cardiac GSH content was elevated by NAC and depleted by BSO (from 7.9 ± 2.0 to 59.3 ± 8.3 nmol/mg and 3.7 ± 1.0 nmol/mg protein, respectively; p < 0.05). Hypoxia did not affect cardiac GSH content in any group. During normoxia, tracer washed out bi-exponentially, with 13.1% ± 1.7% injected dose being retained; this was not affected by GSH augmentation or depletion. Hypoxia significantly increased tracer retention (to 59.1% ± 6.3%, p < 0.05); this effect was not modified by GSH augmentation or depletion. CONCLUSION: Modification of GSH levels had no impact upon the pharmacokinetics or hypoxia selectivity of (64)Cu(ATSM). While thiols may yet prove essential for the intracellular trapping of (64)Cu(ATSM), they are not the determinants of its hypoxia selectivity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13550-014-0040-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2014-08-01 /pmc/articles/PMC4883992/ /pubmed/26055939 http://dx.doi.org/10.1186/s13550-014-0040-8 Text en © Shaughnessy et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Original Research
Shaughnessy, Fiona
Mariotti, Erika
Shaw, Karen P
Eykyn, Thomas R
Blower, Philip J
Siow, Richard
Southworth, Richard
Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM)
title Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM)
title_full Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM)
title_fullStr Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM)
title_full_unstemmed Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM)
title_short Modification of intracellular glutathione status does not change the cardiac trapping of (64)Cu(ATSM)
title_sort modification of intracellular glutathione status does not change the cardiac trapping of (64)cu(atsm)
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883992/
https://www.ncbi.nlm.nih.gov/pubmed/26055939
http://dx.doi.org/10.1186/s13550-014-0040-8
work_keys_str_mv AT shaughnessyfiona modificationofintracellularglutathionestatusdoesnotchangethecardiactrappingof64cuatsm
AT mariottierika modificationofintracellularglutathionestatusdoesnotchangethecardiactrappingof64cuatsm
AT shawkarenp modificationofintracellularglutathionestatusdoesnotchangethecardiactrappingof64cuatsm
AT eykynthomasr modificationofintracellularglutathionestatusdoesnotchangethecardiactrappingof64cuatsm
AT blowerphilipj modificationofintracellularglutathionestatusdoesnotchangethecardiactrappingof64cuatsm
AT siowrichard modificationofintracellularglutathionestatusdoesnotchangethecardiactrappingof64cuatsm
AT southworthrichard modificationofintracellularglutathionestatusdoesnotchangethecardiactrappingof64cuatsm